Connect with us

Health

Monoclonal antibody “cocktail” blocks COVID-19 variants: Study – EurekAlert

A monoclonal antibody ”cocktail” developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains,…

Published

on

Article feature image

IMAGE: James Crowe, Jr., MD, director of the Vanderbilt Vaccine Center (VVC) and Ann Scott Carell Professor in the Departments of Pediatrics and Pathology, Microbiology and Immunology at Vanderbilt.
view more 
Credit: Vanderbilt University Medical Center
A monoclonal antibody “cocktail” developed at Vanderbilt University Medical Center (VUMC) to neutralize the COVID-19 virus is effective against all known strains, or variants, of the virus, according to a report published in the journal Nature…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending